{"data":{"id":"us/10-cfr-35.415","jurisdiction":"us","citation":"10 CFR 35.415","heading":"Safety precautions.","body":"(a) For each patient or human research subject who is receiving brachytherapy and cannot be released under § 35.75, a licensee shall—\n(1) Not quarter the patient or the human research subject in the same room as an individual who is not receiving brachytherapy;\n(2) Visibly post the patient's or human research subject's room with a “Radioactive Materials” sign; and\n(3) Note on the door or in the patient's or human research subject's chart where and how long visitors may stay in the patient's or human research subject's room.\n(b) A licensee shall have applicable emergency response equipment available near each treatment room to respond to a source—\n(1) Dislodged from the patient; and\n(2) Lodged within the patient following removal of the source applicators.\n(c) A licensee shall notify the Radiation Safety Officer, or his or her designee, and an authorized user as soon as possible if the patient or human research subject has a medical emergency or dies.","path":["Title 10—Energy","CHAPTER I—NUCLEAR REGULATORY COMMISSION","PART 35—MEDICAL USE OF BYPRODUCT MATERIAL","Subpart F—Manual Brachytherapy"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-10.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:09Z","sha256":"7b6bc1d2a8392b7dd6ad595a149a2f221be8c23955fcf182a922b56ca6d5ee0c","source_id":"us-cfr","stale":true,"prev":"us/10-cfr-35.410","next":"us/10-cfr-35.432"},"notice":"GroundRules: Original legal text. Not legal advice."}